Independent development of lymphoid and histiocytic malignancies from a shared early precursor

Leukemia. 2016 Apr;30(4):955-8. doi: 10.1038/leu.2015.193. Epub 2015 Jul 23.

Authors

Affiliations

¹ Department of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
² Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Princess Máxima Center for Pediatric Oncology, De Bilt, The Netherlands.
⁴ Department of Pediatric Oncology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

PMID: 26202925
DOI: 10.1038/leu.2015.193

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers, Tumor
Case-Control Studies
Combined Modality Therapy
Female
Follow-Up Studies
Histiocytic Disorders, Malignant
Humans
Immunoenzyme Techniques
Immunophenotyping
Lymphatic Metastasis
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Neoplasm Grading
Neoplasm Invasiveness
Neoplasm Recurrence, Local / drug therapy
Neoplasm Recurrence, Local / pathology
Neoplasm Staging
Neoplasms / drug therapy*
Neoplasms / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Prospective Studies
Survival Rate

Substances

Biomarkers, Tumor